HEALTHBBC HEALTH
UK begins trials of Ebola vaccine developed in just eight weeks
The UK medicines regulator approved trials of an experimental Ebola vaccine for testing on healthy adults. The vaccine was developed in eight weeks, marking a rapid response to the disease.
Related Signal
Adjacent reporting
- UK begins trials of Ebola vaccine developed in just eight weeks
- Ebola vaccine made in UK now ready for trials
- Ebola vaccine for Bundibugyo strain could take months before human trials
- First-ever AI-designed vaccine reaches human trials
- WHO plans Ebola vaccine trials
- First AI-designed ‘universal vaccine’ tested in humans